RNS Number : 9939A
Wickes Group PLC
20 August 2024
 

20th August 2024

Wickes Group plc

("Wickes" or the "Company")

Transaction in Own Shares

 

Wickes Group plc ("Wickes" or the "Company") announces today it has purchased the following number of its ordinary shares of 10 pence each through Peel Hunt LLP ("Peel Hunt").

Ordinary Shares

Date of purchase:

19th August 2024

Number of ordinary shares purchased:

12,714

Lowest price per share (pence):

157.8

Highest price per share (pence):

159.4

Weighted average price per day (pence):

158.5848

 

The Company intends to cancel the purchased shares.

 

Including the above purchases, Wickes has purchased a total of 16,665,856 ordinary shares since the commencement of the buyback programme. 

Following the purchase and cancellation of these shares, the Company's issued share capital will consist of 242,972,142. The Company does not hold any shares in Treasury.

 

Once the shares are cancelled, the total number of voting rights in Wickes will therefore be 242,972,142. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. 

 

The table below contains detailed information about the purchases made as part of the buyback programme.

  

Aggregate information:

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

XLON

158.5848

12,714

157.8

159.4

 

 

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company as part of the Programme is detailed below:

 

Date and time of each trade

Number of shares purchased

Price (pence per share)

Trading Venue

Transaction Reference Number

19th August 2024 09:50:49

7

157.8

XLON

00165628967TRLO0

19th August 2024 09:50:49

712

157.8

XLON

00165628970TRLO0

19th August 2024 11:19:02

1858

159.4

XLON

00165635210TRLO0

19th August 2024 11:23:14

1882

158.8

XLON

00165635404TRLO0

19th August 2024 11:24:05

427

157.8

XLON

00165635431TRLO0

19th August 2024 11:25:25

1857

158

XLON

00165635489TRLO0

19th August 2024 11:25:38

1735

157.8

XLON

00165635502TRLO0

19th August 2024 14:19:43

293

158.6

XLON

00165644026TRLO0

19th August 2024 14:19:43

49

158.6

XLON

00165644027TRLO0

19th August 2024 14:40:51

110

158.8

XLON

00165647006TRLO0

19th August 2024 14:45:46

53

158.8

XLON

00165647611TRLO0

19th August 2024 14:45:46

1666

158.8

XLON

00165647612TRLO0

19th August 2024 14:46:34

154

158.4

XLON

00165647735TRLO0

19th August 2024 14:46:34

119

158.4

XLON

00165647736TRLO0

19th August 2024 14:46:34

23

158.4

XLON

00165647737TRLO0

19th August 2024 14:46:34

6

158.4

XLON

00165647738TRLO0

19th August 2024 15:02:18

49

159.2

XLON

00165649503TRLO0

19th August 2024 15:02:18

49

159.2

XLON

00165649504TRLO0

19th August 2024 15:26:08

1665

159.2

XLON

00165652082TRLO0

 

 

 

 

 

 

For further information please contact:

 

 

Holly Grainger

Director of Investor Relations

07341 680426

holly.grainger@wickes.co.uk

 

Lucy Legh, Will Smith
Headland - PR Adviser to the Company
+44 (0) 0203 805 4822
wickes@headlandconsultancy.com

 

LEI: 213800IEX9ZXJRAOL133

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUKSNRSNUWAAR